How does methotrexate affect elderly patients?

How do methotrexate side effects differ in elderly patients?

Methotrexate is cleared more slowly in older adults because kidney function naturally declines with age. Lower clearance raises drug levels in the blood and increases the chance of toxicity, especially at doses above 10–15 mg per week. Typical signs include mouth sores, nausea, diarrhea, and low blood counts. Liver enzyme elevations are also more common.

How does kidney function change the risk profile?

Creatinine clearance below 60 mL/min is associated with markedly higher rates of severe side effects. Guidelines recommend starting at half the usual dose and titrating slowly while monitoring creatinine every 4–8 weeks. Dose adjustments or temporary stops are advised when clearance falls below 30 mL/min.

What monitoring schedule is recommended for seniors?

Complete blood counts, liver enzymes, and renal function are checked every 2–4 weeks for the first three months, then every 1–3 months once stable. Folate supplementation (1 mg daily or 5 mg weekly) is standard to reduce gastrointestinal and hematologic toxicity.

Can methotrexate be used safely with other medications common in older adults?

Many elderly patients take NSAIDs, PPIs, or diuretics that can further impair methotrexate clearance. Combining these drugs may require more frequent lab checks or dose reductions. Drug interaction checkers and pharmacist review are advised before starting therapy.

When is it reasonable to switch to alternatives?

If renal impairment is severe, or if repeated dose reductions still cause toxicity, clinicians often switch to alternatives such as leflunomide, hydroxychloroquine, or biologic agents. Each option carries its own monitoring needs and cost considerations.